LGALS1 and colitis: Studies have also reported that Galectin-1 ameliorates mouse colitis by conferring oligosaccharide-dependent anti-inflammatory properties on macrophages (29), and the biomaterial containing Galectin-1 inhibits macrophage M1 polarization and promotes M2 polarization, thereby promoting tissue repair (30).